Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
A Multicenter, Open-Labeled, 96-Week Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Indinavir in Combination With Stavudine and Lamivudine in Pediatric Patients With HIV-1 Infection
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
-
San Juan, Puerto Rico, 009367344
- San Juan City Hosp
-
-
-
-
California
-
La Jolla, California, United States, 920930672
- UCSD Med Ctr / Pediatrics / Clinical Sciences
-
San Francisco, California, United States, 941430105
- UCSF / Moffitt Hosp - Pediatric
-
-
Connecticut
-
New Haven, Connecticut, United States, 06504
- Yale Univ Med School
-
-
Florida
-
Gainesville, Florida, United States, 32610
- Univ of Florida Gainesville
-
Jacksonville, Florida, United States, 32209
- Univ of Florida Health Science Ctr / Pediatrics
-
Miami, Florida, United States, 33161
- Univ of Miami (Pediatric)
-
-
Massachusetts
-
Boston, Massachusetts, United States, 021155724
- Children's Hosp of Boston
-
-
New York
-
Great Neck, New York, United States, 11021
- North Shore Univ Hosp
-
New Hyde Park, New York, United States, 11040
- Schneider Children's Hosp
-
New York, New York, United States, 10016
- Bellevue Hosp / New York Univ Med Ctr
-
New York, New York, United States, 10032
- Columbia Presbyterian Med Ctr
-
New York, New York, United States, 10032
- Incarnation Children's Ctr / Columbia Presbyterian Med Ctr
-
Syracuse, New York, United States, 13210
- SUNY Health Sciences Ctr at Syracuse / Pediatrics
-
-
North Carolina
-
Durham, North Carolina, United States, 277103499
- Duke Univ Med Ctr
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 191044318
- Children's Hosp of Philadelphia
-
-
South Carolina
-
Charleston, South Carolina, United States, 294253312
- Med Univ of South Carolina
-
-
Tennessee
-
Memphis, Tennessee, United States, 381052794
- Saint Jude Children's Research Hosp of Memphis
-
-
Washington
-
Seattle, Washington, United States, 981050371
- Children's Hospital & Medical Center / Seattle ACTU
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Your child may be eligible for this study if he/she:
- Is 3 - 15 years old and has consent of a parent or legal guardian who is able to return with the child for follow-up visits.
- Is HIV-positive.
- Is generally healthy.
- Is able to swallow medication in capsule form.
- Has never taken d4T or has never taken 3TC.
- Agrees to use barrier methods of birth control (such as condoms) during the study. The pill is not allowed during the study.
Exclusion Criteria
Your child will not be eligible for this study if he/she:
- Has a serious infection at the time of study entry.
- Has a history of severe diarrhea.
- Is unable to take any of the medications in this study for any reason.
- Has a history of certain serious illnesses.
- Has taken any protease inhibitors (PIs).
- Has taken any non-nucleoside reverse transcriptase inhibitors (NNRTIs), such as efavirenz (EFV), within 2 weeks prior to study entry.
- Has taken certain medications.
- Is pregnant or breast-feeding.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Ross McKinney
- Study Chair: John Sleasman
Study record dates
Study Major Dates
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Infections
- Molecular Mechanisms of Pharmacological Action
- Anti-Infective Agents
- Antiviral Agents
- Reverse Transcriptase Inhibitors
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Anti-HIV Agents
- Anti-Retroviral Agents
- Antimetabolites
- Protease Inhibitors
- HIV Protease Inhibitors
- Viral Protease Inhibitors
- Lamivudine
- Stavudine
- Indinavir
Other Study ID Numbers
Other Study ID Numbers
- ACTG 395
- 11351 (DAIDS ES)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.